• Protocols

• NRGHN014

  OPEN TO ACCRUAL

  P3 Neoadjuvant Immunotherapy w/Response-Adapted Tx vs SOC for Resectable Stage III/IV Cutaneous SCC
  
  

• UW24072

  OPEN TO ACCRUAL

  Phase 1 IFx-Hu2.0 + Pembrolizumab in Advanced or Metastatic Merkel Cell Carcinoma